View More Recent Stories

Oct 9, 2024 08:05AM Ardelyx (ARDX) Announces Publication of a Review Article Exploring the Patient Burden and Therapeutic Landscape of IBS-C in the U.S. in Clinical and Experimental Gastroenterology

Oct 3, 2024 06:07AM Piper Sandler Reiterates Neutral Rating on Ardelyx, Inc (ARDX)

Aug 8, 2024 08:01AM Ardelyx (ARDX) Appoints Eric Foster as Chief Commercial Officer

Aug 5, 2024 06:57AM Ardelyx, Inc (ARDX) PT Raised to $11 at H.C. Wainwright

Aug 1, 2024 04:02PM Ardelyx (ARDX) Tops Q2 EPS by 4c

Jul 19, 2024 09:59AM H.C. Wainwright Reiterates Buy Rating on Ardelyx, Inc (ARDX)

Jul 5, 2024 06:34AM Ardelyx, Inc (ARDX) PT Lowered to $10 at H.C. Wainwright

Jul 3, 2024 07:06AM Ardelyx, Inc (ARDX) PT Lowered to $10 at Citi

Jul 3, 2024 06:39AM Ardelyx, Inc (ARDX) PT Lowered to $12.50 at Ladenburg Thalmann

Jul 2, 2024 02:03PM Piper Sandler Downgrades Ardelyx, Inc (ARDX) to Neutral, 'Xphozah Outlook Too Uncertain For Us'

Jul 2, 2024 12:34PM TD Cowen Reiterates Buy Rating on Ardelyx, Inc (ARDX)

Jul 2, 2024 08:24AM Ardelyx (ARDX) falls 27% after saying will not apply to include XPHOZAH in CMS ESRD PPS TDAPA

Jul 2, 2024 07:02AM Ardelyx (ARDX) to Not File for TDAPA

View More Recent Stories